Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick G Clay

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
The Annals of Pharmacotherapy|January 29, 2003
Pseudo-Parkinson disease secondary to ritonavir-buspirone interactionPatrick G Clay, Molly M Adams
Infectious Diseases and Therapy|November 13, 2014
Noninfectious Diarrhea in HIV Seropositive Individuals: a Review of Prevalence Rates, Etiology, and Management in the Era of Combination Antiretroviral TherapyPatrick G Clay, Rustin D Crutchley
The Annals of Pharmacotherapy|March 28, 2003
Testosterone replacement therapy for bone loss prevention in HIV-infected malesPatrick G Clay, Amy I Lam
Current Therapeutic Research, Clinical and Experimental|March 28, 2014
Complementary and alternative medicine use by patients visiting a free health clinic: A single-site, pilot studyPatrick G Clay, Kevin A Clauson, Alan Glaros
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|May 20, 2011
Safety, Tolerability, and Pharmacokinetics of KP-1461 in Phase I Clinical Studies: A Single Oral Dose Study in Non-HIV-Infected Adults, and a 14-Day Dose-Escalating Study in Highly Antiretroviral-Experienced HIV-Infected AdultsPatrick G Clay, Marypeace McRae, Jean-Pierre Laurent
Positively Aware : the Monthly Journal of the Test Positive Aware Network|March 30, 2007
Managing longterm side effects of HIV therapy. What to look for and tips to useMaurice W Oelklaus, Charlott L Williams, Patrick G Clay
The Annals of Pharmacotherapy|March 2, 2006
Perceived efficacy, indications, and information sources for medically indigent patients and their healthcare providers regarding dietary supplementsPatrick G Clay, Alan G Glaros, Kevin A Clauson
The Annals of Pharmacotherapy|April 17, 2008
Valid treatment options for osteoporosis and osteopenia in HIV-infected personsPatrick G Clay, Laura E Voss, Charlott Williams, et al.
The Annals of Pharmacotherapy|August 17, 2006
Poly-L-lactic acid for facial lipoatrophy in HIVClaudine El-Beyrouty, Vanthida Huang, Courtney J Darnold, et al.
Pharmacotherapy|July 30, 2009
Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjectsMarypeace McRae, Patrick G Clay, Peter L Anderson, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The Annals of Pharmacotherapy|January 29, 2003
Pseudo-Parkinson disease secondary to ritonavir-buspirone interactionPatrick G Clay, Molly M Adams
Infectious Diseases and Therapy|November 13, 2014
Noninfectious Diarrhea in HIV Seropositive Individuals: a Review of Prevalence Rates, Etiology, and Management in the Era of Combination Antiretroviral TherapyPatrick G Clay, Rustin D Crutchley
The Annals of Pharmacotherapy|March 28, 2003
Testosterone replacement therapy for bone loss prevention in HIV-infected malesPatrick G Clay, Amy I Lam
Current Therapeutic Research, Clinical and Experimental|March 28, 2014
Complementary and alternative medicine use by patients visiting a free health clinic: A single-site, pilot studyPatrick G Clay, Kevin A Clauson, Alan Glaros
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|May 20, 2011
Safety, Tolerability, and Pharmacokinetics of KP-1461 in Phase I Clinical Studies: A Single Oral Dose Study in Non-HIV-Infected Adults, and a 14-Day Dose-Escalating Study in Highly Antiretroviral-Experienced HIV-Infected AdultsPatrick G Clay, Marypeace McRae, Jean-Pierre Laurent
Positively Aware : the Monthly Journal of the Test Positive Aware Network|March 30, 2007
Managing longterm side effects of HIV therapy. What to look for and tips to useMaurice W Oelklaus, Charlott L Williams, Patrick G Clay
The Annals of Pharmacotherapy|March 2, 2006
Perceived efficacy, indications, and information sources for medically indigent patients and their healthcare providers regarding dietary supplementsPatrick G Clay, Alan G Glaros, Kevin A Clauson
The Annals of Pharmacotherapy|April 17, 2008
Valid treatment options for osteoporosis and osteopenia in HIV-infected personsPatrick G Clay, Laura E Voss, Charlott Williams, et al.
The Annals of Pharmacotherapy|August 17, 2006
Poly-L-lactic acid for facial lipoatrophy in HIVClaudine El-Beyrouty, Vanthida Huang, Courtney J Darnold, et al.
Pharmacotherapy|July 30, 2009
Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjectsMarypeace McRae, Patrick G Clay, Peter L Anderson, et al.
Pageof 7